Healthcare provider profile · identity verified

Gregory L Hazle, MD

Family Practice · GRAND RAPIDS, MI · NPI 1417995408

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	642	193
Metoprolol Succinate	Metoprolol Succinate	401	112
Levothyroxine Sodium	Levothyroxine Sodium	377	108
Lisinopril	Lisinopril	376	111
Omeprazole	Omeprazole	333	102
Amlodipine Besylate	Amlodipine Besylate	314	88
Losartan Potassium	Losartan Potassium	230	67
Metformin Hcl	Metformin Hcl	198	55
Gabapentin	Gabapentin	179	52
Trulicity	Dulaglutide	161	27
Hydrochlorothiazide	Hydrochlorothiazide	138	45
Tamsulosin Hcl	Tamsulosin Hcl	137	45
Fluoxetine Hcl	Fluoxetine Hcl	130	41
Simvastatin	Simvastatin	127	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	126	36
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	124	36
Metformin Hcl Er	Metformin Hcl	117	38
Allopurinol	Allopurinol	106	29
Eliquis	Apixaban	106	31
Trazodone Hcl	Trazodone Hcl	101	25
Furosemide	Furosemide	100	32
Lovastatin	Lovastatin	95	27
Atenolol	Atenolol	86	24
Meloxicam	Meloxicam	86	31
Albuterol Sulfate Hfa	Albuterol Sulfate	85	32
Zolpidem Tartrate	Zolpidem Tartrate	82	21
Alprazolam	Alprazolam	79	30
Metoprolol Tartrate	Metoprolol Tartrate	76	22
Farxiga	Dapagliflozin Propanediol	71	14
Citalopram Hbr	Citalopram Hydrobromide	67	21
Xarelto	Rivaroxaban	66	18
Carvedilol	Carvedilol	64	21
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	62	15
Pantoprazole Sodium	Pantoprazole Sodium	59	22
Pravastatin Sodium	Pravastatin Sodium	55	16
Venlafaxine Hcl Er	Venlafaxine Hcl	55	14
Pioglitazone Hcl	Pioglitazone Hcl	53	16
Raloxifene Hcl	Raloxifene Hcl	53	14
Sertraline Hcl	Sertraline Hcl	53	19
Fluticasone Propionate	Fluticasone Propionate	51	19
Rosuvastatin Calcium	Rosuvastatin Calcium	51	20
Alendronate Sodium	Alendronate Sodium	50	17
Paroxetine Hcl	Paroxetine Hcl	50	16
Clonidine Hcl	Clonidine Hcl	48	11
Montelukast Sodium	Montelukast Sodium	48	17
Spironolactone	Spironolactone	48	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	47	suppressed
Chlorthalidone	Chlorthalidone	44	12
Ozempic	Semaglutide	43	suppressed
Potassium Chloride	Potassium Chloride	43	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	41	13
Clonazepam	Clonazepam	40	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	40	13
Mounjaro	Tirzepatide	40	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	39	12
Duloxetine Hcl	Duloxetine Hcl	38	15
Finasteride	Finasteride	38	suppressed
Glipizide Er	Glipizide	38	11
Ibuprofen	Ibuprofen	38	15
Amitriptyline Hcl	Amitriptyline Hcl	37	12
Tramadol Hcl	Tramadol Hcl	37	12
Buspirone Hcl	Buspirone Hcl	35	11
Glipizide	Glipizide	35	suppressed
Dutasteride	Dutasteride	33	suppressed
Estradiol	Estradiol	33	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	32	21
Bupropion Hcl Sr	Bupropion Hcl	31	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	13
Prednisone	Prednisone	29	19
Doxazosin Mesylate	Doxazosin Mesylate	28	suppressed
Naproxen	Naproxen	28	suppressed
Ipratropium Bromide	Ipratropium Bromide	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	12
Celecoxib	Celecoxib	26	12
Propranolol Hcl Er	Propranolol Hcl	26	suppressed
Benazepril Hcl	Benazepril Hcl	25	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Spiriva Respimat	Tiotropium Bromide	25	suppressed
Baclofen	Baclofen	24	suppressed
Lansoprazole	Lansoprazole	24	suppressed
Jardiance	Empagliflozin	23	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Sildenafil Citrate	Sildenafil Citrate	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Azithromycin	Azithromycin	20	20
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Hydralazine Hcl	Hydralazine Hcl	19	suppressed
Minocycline Hcl	Minocycline Hcl	19	suppressed
Mometasone Furoate	Mometasone Furoate	19	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	17
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Methocarbamol	Methocarbamol	17	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Testosterone Cypionate	Testosterone Cypionate	15	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Rufinamide	Rufinamide	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	13	suppressed
Phenobarbital	Phenobarbital	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Temazepam	Temazepam	13	suppressed
Topiramate	Topiramate	13	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	12	suppressed
Cilostazol	Cilostazol	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	12	suppressed
Victoza 3-Pak	Liraglutide	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error